Clinical Trials Browser

NCT07371247 2026-01-27

Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy

Phase EARLY_PHASE1 Enrolling by invitation

65 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT06603987 2025-11-19

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

Phase 1/2 Enrolling by invitation

30 enrolled

BreastGastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Neurofibrosarcoma

NCT02427269 2025-05-29

BEECAB

Enrolling by invitation

1,000 enrolled

Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

NCT06990178 2025-05-25

Adaptive Neoadjuvant Therapy for Esophageal Cancer

Phase NA Enrolling by invitation

43 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT05706025 2025-04-06

Study to Evaluate EnteroTracker® as a Sampling Method to Screen for Barrett's Esophagus/Esophageal Cancer

Phase NA Enrolling by invitation

60 enrolled

Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

NCT06690216 2025-03-30

PD-L1-PET

Phase 1/2 Enrolling by invitation

100 enrolled

CNSGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Glioblastoma

NCT06862479 2025-03-10

ES-LCCE-UDFM

Enrolling by invitation

180 enrolled

GastrointestinalOther

Esophageal Neoplasms, Fistula, Obesity, Obesity, Morbid, Stomach Neoplasms, Anastomotic Leak

NCT06587152 2024-09-19

Clinical Trial to Evaluate the Efficacy and Safety of a Thoracic and Abdominal Endoscopic Surgical System

Phase NA Enrolling by invitation

60 enrolled

Gastrointestinal

Esophageal Neoplasms, Colorectal Neoplasms

NCT06160557 2024-01-03

A Clinical Study of Non-curative Resection Plus Radiotherapy After Endoscopic ESD for Superficial Esophageal Squamous Cell Carcinoma

Enrolling by invitation

40 enrolled

Gastrointestinal

Esophageal Neoplasms